Treace Medical Concepts (TMCI) Equity Ratio (2020 - 2026)

Treace Medical Concepts has reported Equity Ratio for 7 years, with the latest figure at 0.42 in Q1 2026.

• For the quarter ending Q1 2026, Equity Ratio fell 18.07% year-over-year to 0.42; the trailing twelve-month figure through Mar 2026 stood at 0.42 (down 18.07% YoY), and the FY2025 full-year result was 0.46, down 11.88% from the prior year.
• Equity Ratio for Q1 2026 stood at 0.42, down from 0.46 in the prior quarter.
• The five-year high for Equity Ratio was 0.63 in Q1 2023, with the low at 0.38 in Q4 2022.
• Historically, Equity Ratio has averaged 0.5 across 5 years, with a median of 0.5 in 2024.
• The largest YoY upside for Equity Ratio was 3338.49% in 2022 against a maximum downside of 43.82% in 2022.
• Treace Medical Concepts' Equity Ratio stood at 0.38 in 2022, then soared by 43.86% to 0.55 in 2023, then fell by 5.03% to 0.52 in 2024, then decreased by 11.88% to 0.46 in 2025, then decreased by 8.5% to 0.42 in 2026.
• The last three Equity Ratio figures came in at 0.42 (Q1 2026), 0.46 (Q4 2025), and 0.45 (Q3 2025), per Business Quant data.